In this buddisode, Tanu and Jatin discuss about a SARS CoV2 patient case study who recovered from non-severe COVID19.
Check out our memes on Facebook (@antibuddies) and Twitter (@antibuddiesP).
Website: <a href="https://antibuddies.org/">Antibuddies – Science Communication & Immunology</a> (Antibuddies.org)
Send us your queries/questions/suggestions at antibuddies1@gmail.com.
Source:
<a href="https://www.nature.com/articles/s41591-020-0819-2">https://www.nature.com/articles/s41591-020-0819-2</a>

In this buddisode, Tanu and Jatin discuss about a SARS CoV2 patient case study who recovered from non-severe COVID19. Check out our memes on Facebook (@antibuddies) and Twitter (@antibuddiesP). Website: Antibuddies – Science Communication & Immunology (Antibuddies.org) Send us your queries/questions/suggestions at antibuddies1@gmail.com. Source: https://www.nature.com/articles/s41591-020-0819-2

In this buddisode, Tanu and Jatin discuss about a SARS CoV2 patient case study who recovered from non-severe COVID19.
Check out our memes on Facebook (@antibuddies) and Twitter (@antibuddiesP).
Website:&nbsp;<a href="https://antibuddies.org/" rel="noopener noreferrer">Antibuddies – Science Communication &amp; Immunology</a> (Antibuddies.org)
Send us your queries/questions/suggestions at antibuddies1@gmail.com.
Source:
<a href="https://www.nature.com/articles/s41591-020-0819-2" rel="noopener noreferrer">https://www.nature.com/articles/s41591-020-0819-2</a>

Share Bep3 - Immunity against COVID19 / SARS CoV2

Sign up to save your podcasts

Bep3 - Immunity against COVID19 / SARS CoV2

Bep3 - Immunity against COVID19 / SARS CoV2